Product Code: SR112023A2277
Abstract
Market Overview 2023-2028:
The global fluorescent in situ hybridization (FISH) probe market size reached US$ 816 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,224 Million by 2028, exhibiting a growth rate (CAGR) of 7.1% during 2023-2028.
Fluorescent in Situ Hybridization (FISH) Probe refers to a sub-atomic cytogenetic technique that uses fluorescent probes to visualize genetic materials. These probes are molecules that absorb light of a specific wavelength and emit light upon binding with a particular DNA/RNA sequence. They are used to identify structural and numerical abnormalities in chromosomes, therapeutic drug monitoring and the identification of rare genetic diseases. Locus specific, Alphoid/centromeric repeat and whole chromosome probes are some of the types of FISH probes that are being commonly used. They exhibit various advantageous properties, such as high sensitivity and accuracy in recognizing targeted sequences, direct application to both metaphase chromosomes and interphase nuclei and accurate visualization of hybrid signals at the single-cell level.
The increasing prevalence of various genetic and chronic disorders is one of the key factors driving the growth of the market. Furthermore, the growing requirements for In Vitro Diagnostics (IVD) testing and targeted therapies across the globe are also boosting the market growth. In comparison to the traditionally used standard cytogenetic (cell gene) tests, FISH tests can identify minute genetic changes that are usually missed under the microscope. These probes are therefore widely used for the diagnosis, prediction of outcomes and clinical management of cancer and genetic disorders. Additionally, various technological advancements, such as the development of FISH probes with higher sensitivity and accuracy, are creating a positive outlook for the market. Other factors, including the improving healthcare infrastructure, especially in the developing countries, along with extensive research and development (R&D) activities in biotechnology, are expected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global fluorescent in situ hybridization (FISH) probe market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, probe type, technology, application and end-user.
Breakup by Type:
DNA
RNA
mRNA
miRNA
Others
Breakup by Probe Type:
Locus Specific Probes
Alphoid/Centromeric Repeat Probes
Whole Chromosome Probes
Breakup by Technology:
Flow FISH
Q FISH
Others
Breakup by Application:
Cancer
Genetic Diseases
Others
Breakup by End-User:
Research Organizations
Diagnostic Centers
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abnova Corporation, Agilent Technologies Inc., Biocare Medical LLC, Biosearch Technologies (LGC Ltd.), Creative Biolabs, F. Hoffmann-La Roche Ltd. (Roche Holding AG), Genemed Biotechnologies Inc. (Sakura Finetek USA Inc.), Merck KGaA, Oxford Gene Technology (Sysmex Corporation), PerkinElmer Inc., ThermoFisher Scientific Inc., etc.
Key Questions Answered in This Report:
- How has the global fluorescent in situ hybridization (FISH) probe market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global fluorescent in situ hybridization (FISH) probe market?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the probe type?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global fluorescent in situ hybridization (FISH) probe market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Fluorescent in Situ Hybridization Probe Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 DNA
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 RNA
- 6.2.1 Market Trends
- 6.2.2 Major Types
- 6.2.2.1 mRNA
- 6.2.2.2 miRNA
- 6.2.2.3 Others
- 6.2.3 Market Forecast
7 Market Breakup by Probe Type
- 7.1 Locus Specific Probes
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Alphoid/Centromeric Repeat Probes
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Whole Chromosome Probes
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Technology
- 8.1 Flow FISH
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Q FISH
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Application
- 9.1 Cancer
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Genetic Diseases
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by End-User
- 10.1 Research Organizations
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Diagnostic Centers
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Others
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
11 Market Breakup by Region
- 11.1 North America
- 11.1.1 United States
- 11.1.1.1 Market Trends
- 11.1.1.2 Market Forecast
- 11.1.2 Canada
- 11.1.2.1 Market Trends
- 11.1.2.2 Market Forecast
- 11.2 Asia Pacific
- 11.2.1 China
- 11.2.1.1 Market Trends
- 11.2.1.2 Market Forecast
- 11.2.2 Japan
- 11.2.2.1 Market Trends
- 11.2.2.2 Market Forecast
- 11.2.3 India
- 11.2.3.1 Market Trends
- 11.2.3.2 Market Forecast
- 11.2.4 South Korea
- 11.2.4.1 Market Trends
- 11.2.4.2 Market Forecast
- 11.2.5 Australia
- 11.2.5.1 Market Trends
- 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
- 11.2.6.1 Market Trends
- 11.2.6.2 Market Forecast
- 11.2.7 Others
- 11.2.7.1 Market Trends
- 11.2.7.2 Market Forecast
- 11.3 Europe
- 11.3.1 Germany
- 11.3.1.1 Market Trends
- 11.3.1.2 Market Forecast
- 11.3.2 France
- 11.3.2.1 Market Trends
- 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
- 11.3.3.1 Market Trends
- 11.3.3.2 Market Forecast
- 11.3.4 Italy
- 11.3.4.1 Market Trends
- 11.3.4.2 Market Forecast
- 11.3.5 Spain
- 11.3.5.1 Market Trends
- 11.3.5.2 Market Forecast
- 11.3.6 Russia
- 11.3.6.1 Market Trends
- 11.3.6.2 Market Forecast
- 11.3.7 Others
- 11.3.7.1 Market Trends
- 11.3.7.2 Market Forecast
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.1.1 Market Trends
- 11.4.1.2 Market Forecast
- 11.4.2 Mexico
- 11.4.2.1 Market Trends
- 11.4.2.2 Market Forecast
- 11.4.3 Others
- 11.4.3.1 Market Trends
- 11.4.3.2 Market Forecast
- 11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast
12 SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Competition
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
15 Price Indicators
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 Abnova Corporation
- 16.3.1.1 Company Overview
- 16.3.1.2 Product Portfolio
- 16.3.1.3 Financials
- 16.3.2 Agilent Technologies Inc.
- 16.3.2.1 Company Overview
- 16.3.2.2 Product Portfolio
- 16.3.2.3 Financials
- 16.3.2.4 SWOT Analysis
- 16.3.3 Biocare Medical LLC
- 16.3.3.1 Company Overview
- 16.3.3.2 Product Portfolio
- 16.3.4 Biosearch Technologies (LGC Ltd.)
- 16.3.4.1 Company Overview
- 16.3.4.2 Product Portfolio
- 16.3.5 Creative Biolabs
- 16.3.5.1 Company Overview
- 16.3.5.2 Product Portfolio
- 16.3.6 F. Hoffmann-La Roche Ltd (Roche Holding AG)
- 16.3.6.1 Company Overview
- 16.3.6.2 Product Portfolio
- 16.3.6.3 SWOT Analysis
- 16.3.7 Genemed Biotechnologies Inc. (Sakura Finetek USA Inc.)
- 16.3.7.1 Company Overview
- 16.3.7.2 Product Portfolio
- 16.3.8 Merck KGaA
- 16.3.8.1 Company Overview
- 16.3.8.2 Product Portfolio
- 16.3.8.3 Financials
- 16.3.8.4 SWOT Analysis
- 16.3.9 Oxford Gene Technology (Sysmex Corporation)
- 16.3.9.1 Company Overview
- 16.3.9.2 Product Portfolio
- 16.3.9.3 Financials
- 16.3.10 PerkinElmer Inc.
- 16.3.10.1 Company Overview
- 16.3.10.2 Product Portfolio
- 16.3.10.3 Financials
- 16.3.10.4 SWOT Analysis
- 16.3.11 ThermoFisher Scientific Inc.
- 16.3.11.1 Company Overview
- 16.3.11.2 Product Portfolio
- 16.3.11.3 Financials
- 16.3.11.4 SWOT Analysis